Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Merck_&_Co.
|
| gptkbp:acquisitionYear |
2015
|
| gptkbp:ceased_operations |
2015
|
| gptkbp:focus |
infectious disease treatments
|
| gptkbp:founded |
1992
|
| gptkbp:founder |
gptkb:John_L._McCarthy
|
| gptkbp:headquartersLocation |
gptkb:Lexington,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cubist Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Cubicin
gptkb:Dificid |
| gptkbp:numberOfEmployees |
about 700 (2014)
|
| gptkbp:specializesIn |
antibiotics
|
| gptkbp:stockSymbol |
gptkb:CBST
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:bfsParent |
gptkb:Cubicin
|
| gptkbp:bfsLayer |
5
|